- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02059928
Intraosseous Pressure Monitoring in Intensive Care Unit Patients
June 5, 2018 updated by: HealthPartners Institute
In emergency situations, access to the venous system is essential in order to administer fluids and medication and to monitor patients.
When peripheral veins are difficult to access or the patient's condition requires certain medications, or monitoring, central venous catheters (CVC) are inserted.
CVC placement introduces a much higher level of risk compared to peripheral catheters.
The technique of intraosseous (IO) infusion has been used by healthcare professionals for several decades, but recently has gained wide popularity in the emergency care settings.
This technique allows providers to secure a needle in the bony matrix at the ends of long bones (tibia and humerus) and infuse fluids and medications into the intramedullary space.
The ability to monitor a patient's blood pressure through an intraosseous needle is unknown.
The primary objective of this study is to describe the relationship (ratio) of intraosseous pressure (IOP) values to standard pressure values, including systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and central venous pressure (CVP).
Study Overview
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients ≥ 18 years old
- Admitted to the surgical intensive care units
- Current central pressure monitoring through a central line
- Patient currently intubated and sedated
- Informed consent obtained from family member
- English speaking patient
Exclusion Criteria:
- Known implanted devices in the humerus or tibia that prohibit placement of the intraosseous needle.
- Known osteoporosis, avascular necrosis, or other bone pathology affecting bone healing.
- Fracture or other significant injury to the tibia or humerus or surrounding musculature/tissue.
- Inability to landmark IO placement due to excessive tissue over placement location.
- Anticipated surgery within 12 hours of time of consent
- Current infection at the placement site.
- Previous, significant orthopedic procedure at the site
- Pregnant or has the potential for being pregnant
- Prisoner of the state
- Minor (< 18 years old)
- Inability to obtain informed consent from family member
- Non-English speaking patient
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intraosseous device placement
Intraosseous device
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standardized Ratio as a Percentage Between Mean IOP and Mean Arterial Pressure
Time Frame: Up to 12 hour data collection period
|
External cuff pressure readings were recorded every 15 minutes, and IO pressure data obtained via pressure transducer was recorded continuously for up to 12 hours.
IO systolic, diastolic, and mean pressure (IO SBP, IO DBP, IO Mean) readings were summarized for the minute before and minute following an external cuff pressure reading.
The ratios as a percentage of IO pressures to external cuff pressures (IO Systolic Blood Pressure / Cuff SBP; IO DBP / Cuff DBP; IO Mean / Cuff Mean) were calculated.
|
Up to 12 hour data collection period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ralph J Frascone, MD, Regions Hospital
- Study Director: Josh Salzman, MA, Regions Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
February 10, 2014
First Submitted That Met QC Criteria
February 10, 2014
First Posted (Estimate)
February 11, 2014
Study Record Updates
Last Update Posted (Actual)
July 3, 2018
Last Update Submitted That Met QC Criteria
June 5, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 13-149
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
GE HealthcareCompleted
-
Taiwan Biophotonic CorporationCompletedBlood Pressure | Blood Pressure VariabilityTaiwan
-
Université de SherbrookeRecruitingBlood Pressure | Blood Pressure Monitoring, Ambulatory | Blood Pressure, High | Blood Pressure ManagementCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Centre Hospitalier Universitaire VaudoisRecruitingBlood Pressure | Blood Pressure DisordersSwitzerland
-
Istituto Auxologico ItalianoCompletedArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
Clinical Trials on Intraosseous Device
-
National Institute of Diabetes and Digestive and...Vidacare CorporationWithdrawnCatheters, Indwelling | Central Venous Line | Intraosseous NeedleUnited States
-
International Institute of Rescue Research and...Completed
-
University of ValenciaEnrolling by invitationTo Compare the Time Required to Administer 1 mg of Epinephrine, as Well as the Total ProcedureSpain
-
The Methodist Hospital Research InstituteNot yet recruitingRevision Total Knee Arthroplasty
-
Lars Wiuff AndersenUniversity of Aarhus; Central Denmark RegionActive, not recruiting
-
Singapore General HospitalSingapore Civil Defence ForceCompleted
-
Rutgers, The State University of New JerseyCompleted
-
Vidacare CorporationCompletedIntraosseous Vascular AccessUnited States
-
Wake Forest University Health SciencesUnited States Department of DefenseNot yet recruiting
-
Vidacare CorporationCompletedVascular AccessUnited States